Product image of Linezolid Kalceks (Linezolid) supplied by GNH India

Linezolid Kalceks

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Kalceks (Linezolid)

Linezolid, the active ingredient in Linezolid Kalceks, is an oxazolidinone antibiotic presented as an intravenous solution for IV use. It treats serious bacterial infections such as complicated skin and soft‑tissue infections, pneumonia, and infections caused by MRSA or VRE in adult patients.
GNH India supplies Linezolid Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Kalceks

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is indicated for bacterial infections that require potent activity against resistant Gram‑positive organisms.

  • Complicated skin and soft tissue infections: resolves infection caused by MRSA and other susceptible pathogens.
  • Community‑acquired and hospital‑acquired pneumonia: provides coverage for typical and atypical organisms, including resistant strains.
  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates MRSA when other agents are ineffective.
  • Vancomycin‑resistant Enterococcus (VRE) infections: offers an alternative option for VRE‑related infections.

How It Works

  • Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks translation, halting bacterial growth and leading to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Diarrhea: loose stools that may be watery.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: altered taste sensation.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count requiring monitoring.
  • Peripheral neuropathy: sensory changes that may be irreversible if untreated.
  • Lactic acidosis: metabolic disturbance with high lactate levels.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Optic neuropathy: visual disturbances that may affect acuity.
  • Myelosuppression: bone‑marrow suppression leading to anemia or leukopenia.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Monitor blood counts: regular CBC to detect thrombocytopenia or anemia.
  • Assess renal function: adjust therapy in severe renal impairment.
  • Avoid serotonergic drugs: linezolid can precipitate serotonin syndrome.
  • Use caution in hepatic disease: liver dysfunction may affect metabolism.
  • Adjust dose for severe renal impairment: follow prescribing information.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Linezolid interacts with several drug classes that may alter efficacy or increase toxicity.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: potential serotonin syndrome.
  • Tricyclic antidepressants: additive serotonergic effects.
  • Meperidine and other opioids with serotonergic activity: heightened serotonin toxicity.

Moderate Interactions (Monitor Closely)

  • Rifampin: induces metabolism, reducing linezolid levels.
  • Antacids containing magnesium or aluminum: may affect absorption.
  • Warfarin: possible alteration of anticoagulant effect, requiring INR monitoring.

Frequently Asked Questions

Linezolid Kalceks is employed for serious Gram‑positive bacterial infections, including complicated skin and soft‑tissue infections, community‑acquired and hospital‑acquired pneumonia, and infections caused by methicillin‑resistant Staphylococcus aureus (MRSA) or vancomycin‑resistant Enterococcus (VRE).

Linezolid blocks bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit, preventing formation of the initiation complex and thereby inhibiting translation. This results in a bacteriostatic effect against susceptible Gram‑positive organisms.

The dosage and duration of Linezolid Kalceks are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local guidelines. No fixed regimen is provided here.

Safety data for linezolid in pregnancy and lactation are limited. Use only if the potential benefit justifies the potential risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Linezolid offers oral and intravenous options and is active against many vancomycin‑resistant strains, whereas vancomycin is limited to IV use and may be less effective against certain resistant organisms. Choice depends on susceptibility patterns, site of infection, and patient-specific factors.

Store Linezolid Kalceks at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and avoid exposure to extreme temperatures.

Linezolid Kalceks is given by intravenous infusion as directed by the prescriber. The infusion rate, dilution, and duration are specified in the prescribing information and should be followed by qualified healthcare personnel.

Serious risks include thrombocytopenia, peripheral neuropathy, lactic acidosis, serotonin syndrome when combined with serotonergic agents, optic neuropathy, and myelosuppression. Patients should be monitored regularly for hematologic and neurologic changes.

Linezolid Kalceks should be avoided in patients with known hypersensitivity to linezolid or any component of the formulation, and it should be used with caution in those taking MAO inhibitors, serotonergic drugs, or with severe renal or hepatic impairment unless specifically advised by a clinician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT